Bryn Kinder

Bryn Kinder has a diverse and extensive work experience, primarily in the life sciences industry. Their most recent position is as the Director of Project Management at Shasqi, where they currently work. Prior to this, they served as the Director of Program Management at Iovance Biotherapeutics, Inc., where they led the Submission Readiness Team for a BLA for a TIL product candidate. Bryn also created a BLA dashboard and developed a PMO toolkit during their time at Iovance.

Before joining Iovance, Bryn worked at Taysha Gene Therapies as the Director of Program Management and later as the Associate Director of Program Management. In these roles, they managed cross-functional program teams for gene therapy development, specifically for Rett Syndrome. They were responsible for driving towards clinical data and potential commercial opportunities.

Bryn has also gained experience at Reata Pharmaceuticals, Inc. in various roles. They served as the Senior Manager of Program Management, where they led the global program management for Bardoxolone Methyl, a drug for chronic kidney disease. They were also a key member of the team responsible for the NDA preparation and submission for Alport syndrome. Bryn also worked as a Project Manager at Reata, where they managed process development, collaborated with multiple functions, and introduced new project management software.

Earlier in their career, Bryn worked at Abbott Diagnostics Business as a Project Manager, overseeing clinical chemistry assays and managing design plans. They also worked at Royal Adhesives & Sealants as an Analytical Research Chemist, where they focused on improving lab efficiency and managing the approval and release of raw materials. Bryn's experience also includes positions at Leica Biosystems as a Research Scientist and an R&D Project Manager, where they led cross-functional projects, launched new products, optimized procedures, and filed a provisional patent.

Bryn’s career began as a research assistant at Bowling Green State University and Northern Illinois University, where they gained experience in nanosensor research. Overall, Bryn Kinder has shown a strong ability to lead cross-functional teams, manage complex projects, and drive towards important milestones in the life sciences industry.

Bryn Kinder obtained a Master of Science (M.S.) degree in Chemistry from Bowling Green State University. The specific dates of their enrollment are not provided.

In 2013, Bryn attended McHenry County College, where they completed coursework in Microsoft Project 2010 Advanced. Additionally, they obtained a certificate in Project Management Professionals (PMP) Essentials during the same year.

Prior to attending McHenry County College, Bryn earned a Bachelors of Science degree in Chemistry from Northern Illinois University. Again, the specific dates of enrollment are unknown.

Earlier in their education, Bryn attended Elgin Community College from 2003 to 2008, where they obtained an Associates degree with a focus on Science and Art.

In terms of additional certifications, Bryn has received the following:

- "Preventing Discrimination & Harassment: CA Employees V4.01 2022" from Traliant in September 2022

- "Selecting and Managing a Project Portfolio with Microsoft Project" from LinkedIn in August 2018

- "Good Clinical Practice (US FDA Focus)" from CITI Program, A Division of BRANY in January 2019

Bryn has also completed various courses through Smartly by Pedago, LLC, including "Accounting I: Fundamentals," "Finance: Time Value of Money," "Marketing Fundamentals," "Microeconomics I: Supply and Demand," "One-Variable Statistics," and "Two-Variable Statistics." However, the specific dates of completion are not provided.